Literature DB >> 8832254

The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease.

E A Walker1, M D Gelfand, A N Gelfand, F Creed, W J Katon.   

Abstract

Although prior theories about psychiatric disorders causing inflammatory bowel disease (IBD) have largely been discredited, these same disorders have at times been associated with functional gastrointestinal symptoms such as those found in irritable bowel syndrome. Since functional gastrointestinal symptoms can also occur in patients with organic pathology, we hypothesized that a current psychiatric disorder might amplify or produce additional gastrointestinal symptoms in patients with organic gastrointestinal diseases such as IBD, leading to additive functional disability and decreased quality of life. This pilot study evaluated a sequential sample of 40 IBD patients using the NIMH Diagnostic Interview Schedule, structured interviews for functional gastrointestinal symptoms, and prior episodes of emotional, physical, and sexual abuse as well as self-report measures of personality and disability. We compared IBD patients with and without a current psychiatric disorder while controlling for disease severity. Eight patients with major depression were treated with antidepressants. Patients with a current psychiatric disorder had significantly higher 1) mean number of lifetime psychiatric diagnoses, 2) prevalence rates of prior sexual and physical victimization, and, 3) mean numbers of both gastrointestinal and other medically unexplained symptoms despite no differences in severity of IBD. Significant and trend level differences were apparent on several measures of functional disability. A regression analysis showed that number of psychiatric diagnoses, number of functional gastrointestinal symptoms, and dissociation scale scores significantly discriminated the groups. Treatment of current major depression decreased functional disability despite no objective changes in gastrointestinal disease severity. It was concluded that the presence of a current psychiatric disorder appears to alter the perception of disease severity in patients with IBD. Nonrecognition of the psychiatric disorder may lead to unnecessary and aggressive interventions for IBD patients such as medication changes, invasive testing, or surgery. The presence of a current psychiatric illness also appears to be associated with increased functional disability. Psychiatric evaluation and treatment, therefore, have an important role in the ongoing management of IBD patients with distressing gastrointestinal symptoms not directly attributable to their IBD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832254     DOI: 10.1016/0163-8343(96)00036-9

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  26 in total

1.  Infliximab, a TNF-α antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level.

Authors:  I Ertenli; S Ozer; S Kiraz; S B Apras; A Akdogan; O Karadag; M Calguneri; U Kalyoncu
Journal:  Rheumatol Int       Date:  2010-11-16       Impact factor: 2.631

2.  Psychological distress, somatization, and defense mechanisms associated with quality of life in inflammatory bowel disease patients.

Authors:  Thomas N Hyphantis; Barbara Tomenson; Marina Bai; Epameinondas Tsianos; Venetsanos Mavreas; Francis Creed
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

Review 3.  Pain and inflammatory bowel disease.

Authors:  Klaus Bielefeldt; Brian Davis; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

4.  Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease.

Authors:  Wendy N Gray; Lee A Denson; Robert N Baldassano; Kevin A Hommel
Journal:  Inflamm Bowel Dis       Date:  2010-11-04       Impact factor: 5.325

5.  Narcotic use for inflammatory bowel disease and risk factors during hospitalization.

Authors:  Millie D Long; Edward L Barnes; Hans H Herfarth; Douglas A Drossman
Journal:  Inflamm Bowel Dis       Date:  2011-07-07       Impact factor: 5.325

Review 6.  Comorbidity in inflammatory bowel disease.

Authors:  Antonio López San Román; Fernando Muñoz
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

7.  Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients.

Authors:  Arvind I Srinath; Alka Goyal; Lori A Zimmerman; Melissa C Newara; Margaret A Kirshner; Francis Nicole McCarthy; David Keljo; David Binion; Athos Bousvaros; David R DeMaso; Ada Youk; Eva M Szigethy
Journal:  Inflamm Bowel Dis       Date:  2014-08       Impact factor: 5.325

8.  Inflammatory bowel disease in children: psychological and psychiatric issues.

Authors:  Parikshit Deshmukh; Gaurav Kulkarni; Jeanne Lackamp
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

9.  Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression.

Authors:  Jean-Eric Ghia; Patricia Blennerhassett; Stephen M Collins
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 10.  Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?

Authors:  Jason S Reich; Francis A Farraye; Sharmeel K Wasan
Journal:  Dig Dis Sci       Date:  2016-04-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.